AMPH
Amphastar P
NASDAQ: AMPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$28.87
+0.94% today
Updated 2026-11-12
Market cap
$1.22B
P/E ratio
13.12
P/S ratio
1.64x
EPS (TTM)
$2.18
Dividend yield
—
52W range
$17 – $31
Volume
0.5M
Amphastar P (AMPH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$28.87
12-Month target
$15.66
2030 Target
$37.06
Intrinsic (DCF)
$39.87
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.4B | $0.5B | $0.6B | $0.7B | $0.7B | $0.8B | $1.0B | $1.1B | $1.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 15.53% (capped 20%) · P/E: 13.12x (capped 25x) · Margin: 13.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.